These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27975172)

  • 1. Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2018 Jan; 55(1):402-408. PubMed ID: 27975172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinicopathological significance of Nck1 in human astrocytoma progression.
    Deshpande RP; Panigrahi M; Y B V K CS; Babu PP
    Int J Neurosci; 2019 Feb; 129(2):171-178. PubMed ID: 30146921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
    Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher YAP1 Levels Are Associated With Shorter Survival of Patients With Low Grade Astrocytoma.
    Dicke J; Hero L; Kuhl S; Görtz L; Goldbrunner R; Timmer M
    Anticancer Res; 2024 Jul; 44(7):3005-3011. PubMed ID: 38925840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.
    Fan W; Fan SS; Feng J; Xiao D; Fan S; Luo J
    PLoS One; 2017; 12(10):e0185563. PubMed ID: 29028811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients.
    Li WQ; Zhong NZ; He J; Li YM; Hou LJ; Liu HM; Xia CY; Wang LZ; Lu YC
    Oncol Rep; 2017 May; 37(5):2865-2874. PubMed ID: 28339043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
    Ding Y; Yu S; Bao Z; Liu Y; Liang T
    J Neurooncol; 2017 May; 133(1):87-95. PubMed ID: 28432586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma.
    Li J; Zhang H; Wu J; Guan H; Yuan J; Huang Z; Li M
    Int J Cancer; 2010 Mar; 126(6):1436-44. PubMed ID: 19676046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression microarray analysis reveals prognostic markers of survival in high grade astrocytomas.
    Yang J; Hou Z; Wang C; Wang H; Zhang H
    Neurol Res; 2018 Sep; 40(9):744-751. PubMed ID: 29781781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
    Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
    Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.
    Zhi F; Wang Q; Xue L; Shao N; Wang R; Deng D; Wang S; Xia X; Yang Y
    PLoS One; 2015; 10(8):e0135242. PubMed ID: 26252651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
    Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
    J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
    Asslaber M; Schauer S; Gogg-Kamerer M; Bernhart E; Quehenberger F; Haybaeck J
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):16-26. PubMed ID: 28040794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.
    Virga J; Bognár L; Hortobágyi T; Zahuczky G; Csősz É; Kalló G; Tóth J; Hutóczki G; Reményi-Puskár J; Steiner L; Klekner A
    Pathol Oncol Res; 2018 Jan; 24(1):35-43. PubMed ID: 28161812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma.
    Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q
    J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.